Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trial

To determine if use of antiplatelet or anticoagulant (AP/AC) medication influences visual acuity in patients with active neovascular age-related macular degeneration (N-AMD).

Source: American Journal of Ophthalmology - January 9, 2018 Category: Opthalmology Authors: Gabri ëlle H.S. Buitendijk, Ann-Sofie M.E. Schauwvlieghe, Johannes R. Vingerling, Reinier O. Schlingemann, Caroline C.W. Klaver, comparing Bevacizumab to Ranibizumab in Age-related Macular Degeneration (BRAMD) trial research group Tags: Original Articles Source Type: research